CONCHITA PAZ: Open Payments
NPI 1316982366 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 63 payments from 15 companies in 2025. Trend: 2023 $1,576 · 2024 $3,048 · 2025 $1,738
Food & beverage: $1,722Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $524 |
| AstraZeneca Pharmaceuticals LP | 16 | $501 |
| ABBVIE INC. | 12 | $202 |
| Lilly USA, LLC | 7 | $128 |
| Nalu Medical, Inc. | 1 | $112 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Exact Sciences Corporation | 2 | $41 |
| Radius Health, Inc. | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
Products named: Ozempic, AIRSUPRA, Wegovy, FARXIGA, Nalu Neurostimulation System, LINZESS, MOUNJARO, JARDIANCE.
Industry payments across NM — which companies pay providers there.
